Loteprednol Etabonate Suspension/ Drops
Product Images NDC 72603-324

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Loteprednol Etabonate (NDC 72603-324). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rxllc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton-5ml (Carton 5ml)

This is a description of an ophthalmic suspension called Loteprednol Etabonate. The suspension is preserved and should be shaken vigorously before use. It is for ophthalmic use only, and the text mentions to keep it out of the reach of children and not to freeze it. The product is manufactured in India by GIDRUGS and distributed by Norgsta Rx LLC in Memphis. The text also includes product details like its volume, the presence of Borzakanum Chorde Soion as an added ingredient, and the osmolarity.*

FDA Label Image

Label-5ml (Label 5ml)

This text provides information about a sterile loteprednol etabonate ophthalmic suspension manufactured by Sun Pharmaceutical Medicare Ltd. in India. Each mL contains 5mg (0.5%) of the active ingredient. It is advised to store the product upright between 20°C to 25°C (68°F to 77°F) and not to freeze it. Manufactured for Northstar Rx LLC in Memphis, TN, the product is for ophthalmic use only. The expiration date indicated is in May 2024.*

FDA Label Image

Structure (Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.